Literature DB >> 12815099

R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms.

Tatsuyoshi Kawamura1, Forrest O Gulden, Makoto Sugaya, David T McNamara, Debra L Borris, Michael M Lederman, Jan M Orenstein, Peter A Zimmerman, Andrew Blauvelt.   

Abstract

Langerhans cells (LCs) are suspected to be initial targets for HIV after sexual exposure (by becoming infected or by capturing virus). Here, productive R5 HIV infection of LC ex vivo and LC-mediated transmission of virus to CD4+ T cells were both found to depend on CCR5. By contrast, infection of monocyte-derived dendritic cells and transfer of infection from monocyte-derived dendritic cells to CD4+ T cells were mediated by CCR5-dependent as well as DC-specific ICAM-3-grabbing nonintegrin-dependent pathways. Furthermore, in 62 healthy individuals, R5 HIV infection levels in LCs ex vivo were associated with CCR5 genotype. Specifically, genotyping for ORF Delta 32 revealed that LCs isolated from ORF Delta 32/wt individuals were significantly less susceptible to HIV when compared with LCs isolated from ORFwt/wt individuals (P = 0.016). Strikingly, further genetic analyses of the A-2459G CCR5 promoter polymorphism in ORF Delta 32/wt heterozygous individuals revealed that LCs isolated from -2459A/G + ORF Delta 32/wt individuals were markedly less susceptible to HIV than were LCs from -2459A/A + ORF Delta 32/wt individuals (P = 0.012). Interestingly, these genetic susceptibility data in LCs parallel those of genetic susceptibility studies performed in cohorts of HIV-infected individuals. Thus, we suggest that CCR5-mediated infection of LCs, and not capture of virus by LCs, provides a biologic basis for understanding certain aspects of host genetic susceptibility to initial HIV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815099      PMCID: PMC166241          DOI: 10.1073/pnas.1432450100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  48 in total

1.  Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.

Authors:  E Gonzalez; M Bamshad; N Sato; S Mummidi; R Dhanda; G Catano; S Cabrera; M McBride; X H Cao; G Merrill; P O'Connell; D W Bowden; B I Freedman; S A Anderson; E A Walter; J S Evans; K T Stephan; R A Clark; S Tyagi; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.

Authors:  P A Zimmerman; A Buckler-White; G Alkhatib; T Spalding; J Kubofcik; C Combadiere; D Weissman; O Cohen; A Rubbert; G Lam; M Vaccarezza; P E Kennedy; V Kumaraswami; J V Giorgi; R Detels; J Hunter; M Chopek; E A Berger; A S Fauci; T B Nutman; P M Murphy
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

4.  The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Authors:  N L Michael; G Chang; L G Louie; J R Mascola; D Dondero; D L Birx; H W Sheppard
Journal:  Nat Med       Date:  1997-03       Impact factor: 53.440

5.  The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons.

Authors:  S Mummidi; S S Ahuja; B L McDaniel; S K Ahuja
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells.

Authors:  J Hu; M B Gardner; C J Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

Authors:  M Marmor; H W Sheppard; D Donnell; S Bozeman; C Celum; S Buchbinder; B Koblin; G R Seage
Journal:  J Acquir Immune Defic Syndr       Date:  2001-08-15       Impact factor: 3.731

8.  Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans.

Authors:  P An; M P Martin; G W Nelson; M Carrington; M W Smith; K Gong; D Vlahov; S J O'Brien; C A Winkler
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

9.  Characterization of high-risk HIV-1 seronegative hemophiliacs.

Authors:  J R Salkowitz; S F Purvis; H Meyerson; P Zimmerman; T R O'Brien; L Aledort; M E Eyster; M Hilgartner; C Kessler; B A Konkle; G C White; J J Goedert; M M Lederman
Journal:  Clin Immunol       Date:  2001-02       Impact factor: 3.969

10.  Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C.

Authors:  Sarah C Ball; Awet Abraha; Kalonji R Collins; Andre J Marozsan; Heather Baird; Miguel E Quiñones-Mateu; Adam Penn-Nicholson; Michael Murray; Nathalie Richard; Michael Lobritz; Peter A Zimmerman; Tatsuyoshi Kawamura; Andrew Blauvelt; Eric J Arts
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  79 in total

Review 1.  Dangerous liaisons at the virological synapse.

Authors:  Vincent Piguet; Quentin Sattentau
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

Review 2.  Interactions between HIV-1 and mucosal cells in the female reproductive tract.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-04-01       Impact factor: 3.886

3.  Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification.

Authors:  Renato S Aguiar; Luciana J Costa; Helena S Pereira; Rodrigo M Brindeiro; Amilcar Tanuri
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.

Authors:  Janelle R Salkowitz; Shannon E Bruse; Howard Meyerson; Hernan Valdez; Donald E Mosier; Clifford V Harding; Peter A Zimmerman; Michael M Lederman
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

5.  Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates.

Authors:  Gabriel Catano; Zoya A Chykarenko; Andrea Mangano; J-M Anaya; Weijing He; Alison Smith; Rosa Bologna; Luisa Sen; Robert A Clark; Andrew Lloyd; Ludmila Shostakovich-Koretskaya; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

Review 6.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

7.  Human immunodeficiency virus fusion to dendritic cells declines as cells mature.

Authors:  Marielle Cavrois; Jason Neidleman; Jason F Kreisberg; David Fenard; Christian Callebaut; Warner C Greene
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

9.  Stimulation of HIV-1 replication in immature dendritic cells in contact with primary CD4 T or B lymphocytes.

Authors:  Vincent Holl; Ke Xu; Maryse Peressin; Alexandre Lederle; Marina Elizabeth Biedma; Maryse Delaporte; Thomas Decoville; Sylvie Schmidt; Géraldine Laumond; Anne-Marie Aubertin; Christiane Moog
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

Review 10.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.